clinical trial · NCT06834165
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
ARS Pharmaceuticals, Inc.·phase4·recruiting·n = 600
Allergic ReactionsNeffyAdrenaline
brief summary
The study is to assess the safety of neffy or IM Adrenalin in patients who are experiencing allergic reactions after an OFC, allergen Immunotherapy (AIT), or other allergy challenge that may require epinephrine intervention.
started
May 20, 2025
primary completion
Apr 1, 2027
completion
Jun 1, 2027
last updated
Apr 21, 2026
official title
A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol